Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Gogia

Showing results (111-120 of 179) with videos related to

Pageof 18
Sort By:
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|March 1, 2017
Mixed Phenotypic Acute Leukemia (mixed myeloid/B-cell) with Myeloid Sarcoma of the Thyroid Gland: A Rare Entity with Rarer Asssociation - Detected on FDG PET/CTGaurav Khanna, Nishikant Avinash Damle, Shipra Agarwal, et al.
Indian Journal of Cancer|March 5, 2019
Clinico-pathological characteristics and treatment outcome in invasive lobular carcinoma of the breast: An Indian experienceAjay Gogia, Vinod Raina, Surya Vansham Suryanarayan Deo, et al.
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Clinical Epigenetics|June 3, 2017
Genome-wide DNA methylation profiling integrated with gene expression profiling identifies <i>PAX9</i> as a novel prognostic marker in chronic lymphocytic leukemiaLata Rani, Nitin Mathur, Ritu Gupta, et al.
JCO Global Oncology|September 9, 2025
Comprehensive Overview of Breast Cancer in IndiaTryambak Pratap Srivastava, Isha Goel, Ajay Gogia, et al.
Springerplus|June 20, 2015
Circulating cell-free DNA and its integrity as a prognostic marker for breast cancerSobuhi Iqbal, Sreenivas Vishnubhatla, Vinod Raina, et al.
Breast Cancer Research and Treatment|February 25, 2025
Somatostatin receptor-targeted theranostics in patients with estrogen receptor-positive metastatic breast cancer-a prospective exploratory studyKunal Ramesh Chandekar, Swayamjeet Satapathy, Yamini Dharmashaktu, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 25, 2022
The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor Prognosis in DLBCLMoien Lone, Mahaiwon Shadang, Qulsum Akhter, et al.
Cancer Treatment and Research Communications|April 30, 2026
Pertuzumab-Docetaxel-Trastuzumab regimen in HER2-positive metastatic breast cancer: Real-world data from IndiaAjay Gogia, Atul Batra, Ashutosh Mishra, et al.
Pageof 18

Showing results (111-120 of 179) with videos related to

Sort By:
Pageof 18
Indian Journal of Nuclear Medicine : IJNM : the Official Journal of the Society of Nuclear Medicine, India|March 1, 2017
Mixed Phenotypic Acute Leukemia (mixed myeloid/B-cell) with Myeloid Sarcoma of the Thyroid Gland: A Rare Entity with Rarer Asssociation - Detected on FDG PET/CTGaurav Khanna, Nishikant Avinash Damle, Shipra Agarwal, et al.
Indian Journal of Cancer|March 5, 2019
Clinico-pathological characteristics and treatment outcome in invasive lobular carcinoma of the breast: An Indian experienceAjay Gogia, Vinod Raina, Surya Vansham Suryanarayan Deo, et al.
Experimental Cell Research|September 13, 2020
Prognostic and therapeutic relevance of phosphofructokinase platelet-type (PFKP) in breast cancerSheikh Mohammad Umar, Akanksha Kashyap, Shruti Kahol, et al.
Clinical Epigenetics|June 3, 2017
Genome-wide DNA methylation profiling integrated with gene expression profiling identifies <i>PAX9</i> as a novel prognostic marker in chronic lymphocytic leukemiaLata Rani, Nitin Mathur, Ritu Gupta, et al.
JCO Global Oncology|September 9, 2025
Comprehensive Overview of Breast Cancer in IndiaTryambak Pratap Srivastava, Isha Goel, Ajay Gogia, et al.
Springerplus|June 20, 2015
Circulating cell-free DNA and its integrity as a prognostic marker for breast cancerSobuhi Iqbal, Sreenivas Vishnubhatla, Vinod Raina, et al.
Breast Cancer Research and Treatment|February 25, 2025
Somatostatin receptor-targeted theranostics in patients with estrogen receptor-positive metastatic breast cancer-a prospective exploratory studyKunal Ramesh Chandekar, Swayamjeet Satapathy, Yamini Dharmashaktu, et al.
Technology in Cancer Research & Treatment|February 17, 2026
β-Catenin-Facilitated Glycolytic Reprogramming Fuels TNBC Progression: Therapeutic Blockade with XAV939Sheikh Mohammad Umar, Shruti Kahol, Sandeep R Mathur, et al.
Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 25, 2022
The Expression of the RUVBL1 Component of the R2TP Complex Correlates with Poor Prognosis in DLBCLMoien Lone, Mahaiwon Shadang, Qulsum Akhter, et al.
Cancer Treatment and Research Communications|April 30, 2026
Pertuzumab-Docetaxel-Trastuzumab regimen in HER2-positive metastatic breast cancer: Real-world data from IndiaAjay Gogia, Atul Batra, Ashutosh Mishra, et al.
Pageof 18